Analyst Ratings for MediciNova (MNOV)
MNOV Rating Summary
MNOV Price Target Summary
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$8.25 (+363.5%)
* Over Last 12-Mos
Rating Score: 10 / 10
Percentile Rank: 95%
Avg. $ Target:
$8.25 (+363.5%)
* Over Last 12-Mos
Rating Score: 10 / 10
Percentile Rank: 95%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 9/17/2026 | Roth/MKM | Boobalan Pachaiyappan | New Coverage | Buy (N/A) |
6.00 (N/A) |
2.02 (1.78) |
-11.88% | Details |
| 3/23/2026 | Maxim Group | Jason McCarthy | New Coverage | Buy (N/A) |
6.00 (N/A) |
1.56 (1.78) |
14.1% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
